Provided by Tiger Trade Technology Pte. Ltd.

Entera Bio Ltd.

2.86
-0.0300-1.04%
Post-market: 2.860.00000.00%19:30 EDT
Volume:100.70K
Turnover:288.63K
Market Cap:494.78M
PE:-8.09
High:2.90
Open:2.89
Low:2.82
Close:2.89
52wk High:4.20
52wk Low:0.9100
Shares:173.00M
Float Shares:139.65M
Volume Ratio:0.21
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3536
EPS(LYR):-0.2476
ROE:-138.92%
ROA:-45.98%
PB:68.10
PE(LYR):-11.55

Loading ...

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

GlobeNewswire
·
Jun 15

Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)

TIPRANKS
·
Jun 01

Entera Bio announces annual shareholder meeting notice

Reuters
·
May 15

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Entera Bio (ENTX) and Merck & Company (MRK)

TIPRANKS
·
May 11

Entera Bio Faces Elevated Operational Risks Amid Escalating Middle East Geopolitical Tensions

TIPRANKS
·
May 10

Entera Bio files to sell 19.57M ordinary shares for holders

TIPRANKS
·
May 09

Israel's Entera Bio Q1 net loss widens on higher R&D costs

Reuters
·
May 09

Entera Bio Q1 FY26 net loss widens to $3.5 million

Reuters
·
May 09

Entera Bio Q1 EPS $(0.07) Beats $(0.08) Estimate

Benzinga Earnings
·
May 09

Press Release: Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs

Dow Jones
·
May 09

Entera Bio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 27

Entera Bio prices $10 million private placement led by BVF Partners

Reuters
·
Apr 07

Entera Bio prices USD 10 million private placement led by BVF Partners

Reuters
·
Apr 02

Stock Market Today: S&P 500, Dow Futures Gain As Trump Calls Iran's New Leaders 'Very Reasonable'—Palantir, Rezolve AI, Entera Bio In Focus

Benzinga_recent_news
·
Mar 30

Phreesia, Progress Software And 3 Stocks To Watch Heading Into Monday

Benzinga Earnings
·
Mar 30